Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease.

Rudnick DA, Perlmutter DH.

Hepatology. 2005 Sep;42(3):514-21. Review.

PMID:
16044402
2.
3.
4.

Autophagic disposal of the aggregation-prone protein that causes liver inflammation and carcinogenesis in alpha-1-antitrypsin deficiency.

Perlmutter DH.

Cell Death Differ. 2009 Jan;16(1):39-45. doi: 10.1038/cdd.2008.103. Epub 2008 Jul 11. Review.

5.

Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy.

Teckman JH.

COPD. 2013 Mar;10 Suppl 1:35-43. doi: 10.3109/15412555.2013.765839. Review.

PMID:
23527737
6.

[Heterozygous alpha-1-antitrypsin deficiency (PiMZ): risk factor in the development of primary liver carcinoma in non-cirrhotic liver?].

Manekeller S, Sauerbruch T, Fischer HP, Propping P, Hirner A.

Z Gastroenterol. 2010 Oct;48(10):1211-4. doi: 10.1055/s-0029-1245204. Epub 2010 Sep 30. Review. German.

PMID:
20886426
7.

Genetics of alpha 1-antitrypsin deficiency in relation to neonatal liver disease.

Povey S.

Mol Biol Med. 1990 Apr;7(2):161-72. Review.

PMID:
2188061
8.

Alpha1-antitrypsin deficiency in childhood.

Teckman JH.

Semin Liver Dis. 2007 Aug;27(3):274-81. Review.

PMID:
17682974
9.

Molecular pathogenesis of alpha-1-antitrypsin deficiency-associated liver disease: a meeting review.

Perlmutter DH, Brodsky JL, Balistreri WF, Trapnell BC.

Hepatology. 2007 May;45(5):1313-23. Review.

PMID:
17464974
10.

Review: alpha 1-antitrypsin deficiency associated liver disease.

Qu D, Teckman JH, Perlmutter DH.

J Gastroenterol Hepatol. 1997 May;12(5):404-16. Review.

PMID:
9195389
11.

Alpha-1-antitrypsin deficiency: biochemistry and clinical manifestations.

Perlmutter DH.

Ann Med. 1996 Oct;28(5):385-94. Review.

PMID:
8949968
12.

Hepatic fibrosis and carcinogenesis in α1-antitrypsin deficiency: a prototype for chronic tissue damage in gain-of-function disorders.

Perlmutter DH, Silverman GA.

Cold Spring Harb Perspect Biol. 2011 Mar 1;3(3). pii: a005801. doi: 10.1101/cshperspect.a005801. Review.

13.

Alpha-1-antitrypsin deficiency.

Perlmutter DH.

Semin Liver Dis. 1998;18(3):217-25. Review.

PMID:
9773422
14.

Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a review.

Kok KF, Wahab PJ, Houwen RH, Drenth JP, de Man RA, van Hoek B, Meijer JW, Willekens FL, de Vries RA.

Neth J Med. 2007 May;65(5):160-6. Review.

15.

Liver disease in alpha 1-antitrypsin deficiency: a review.

Fairbanks KD, Tavill AS.

Am J Gastroenterol. 2008 Aug;103(8):2136-41; quiz 2142. doi: 10.1111/j.1572-0241.2008.01955.x. Review.

PMID:
18796107
16.

Alpha-1 antitrypsin and liver disease: mechanisms of injury and novel interventions.

Teckman JH, Mangalat N.

Expert Rev Gastroenterol Hepatol. 2015 Feb;9(2):261-8. doi: 10.1586/17474124.2014.943187. Epub 2014 Jul 28. Review.

PMID:
25066184
17.

Liver injury in alpha 1-antitrypsin deficiency.

Perlmutter DH.

Clin Liver Dis. 2000 May;4(2):387-408, vi. Review.

PMID:
11232197
18.

Alpha-1-antitrypsin deficiency: diagnosis and treatment.

Perlmutter DH.

Clin Liver Dis. 2004 Nov;8(4):839-59, viii-ix. Review.

PMID:
15464658
19.

Malignant liver disease in alpha 1-antitrypsin deficiency.

Poley JR.

Acta Paediatr Suppl. 1994 Feb;393:27-32. Review. No abstract available.

PMID:
8032114
20.

Supplemental Content

Support Center